​

Nephros (NEPH) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Nephros Revenue Highlights

Latest Revenue (Y)

$14.16M

Latest Revenue (Q)

$4.88M

Main Segment (Y)

Royalty and Other Revenues

Nephros Revenue by Period

Nephros Revenue by Year

DateRevenueChange
2024-12-31$14.16M-0.53%
2023-12-31$14.24M42.74%
2022-12-31$9.97M-4.12%
2021-12-31$10.40M21.53%
2020-12-31$8.56M-17.16%
2019-12-31$10.33M81.71%
2018-12-31$5.69M49.30%
2017-12-31$3.81M64.18%
2016-12-31$2.32M19.34%
2015-12-31$1.94M11.21%
2014-12-31$1.75M0.46%
2013-12-31$1.74M-3.71%
2012-12-31$1.81M-18.38%
2011-12-31$2.21M-24.64%
2010-12-31$2.94M10.41%
2009-12-31$2.66M80.65%
2008-12-31$1.47M23.16%
2007-12-31$1.20M50.73%
2006-12-31$793.49K-67.27%
2005-12-31$2.42M1651.72%
2004-12-31$138.41K100.00%
2003-12-31-100.00%
2002-12-31--100.00%
2001-12-31$300.00K-

Nephros generated $14.16M in revenue during NA 2024, up -0.53% compared to the previous quarter, and up 137.04% compared to the same period a year ago.

Nephros Revenue by Quarter

DateRevenueChange
2025-03-31$4.88M26.02%
2024-12-31$3.87M10.01%
2024-09-30$3.52M8.18%
2024-06-30$3.25M-7.67%
2024-03-31$3.52M8.24%
2023-12-31$3.25M-13.04%
2023-09-30$3.74M5.56%
2023-06-30$3.54M-4.11%
2023-03-31$3.70M44.53%
2022-12-31$2.56M6.19%
2022-09-30$2.41M-16.47%
2022-06-30$2.88M31.87%
2022-03-31$2.19M-20.90%
2021-12-31$2.77M4.85%
2021-09-30$2.64M16.37%
2021-06-30$2.27M-17.18%
2021-03-31$2.74M17.22%
2020-12-31$2.33M10.04%
2020-09-30$2.12M34.50%
2020-06-30$1.58M-37.64%
2020-03-31$2.53M-19.99%
2019-12-31$3.16M2.13%
2019-09-30$3.10M34.04%
2019-06-30$2.31M30.53%
2019-03-31$1.77M9.74%
2018-12-31$1.61M-6.50%
2018-09-30$1.72M26.21%
2018-06-30$1.37M38.68%
2018-03-31$985.00K-24.23%
2017-12-31$1.30M41.92%
2017-09-30$916.00K6.64%
2017-06-30$859.00K17.03%
2017-03-31$734.00K-1.48%
2016-12-31$745.00K56.84%
2016-09-30$475.00K-6.68%
2016-06-30$509.00K-13.73%
2016-03-31$590.00K15.46%
2015-12-31$511.00K59.69%
2015-09-30$320.00K-43.56%
2015-06-30$567.00K4.23%
2015-03-31$544.00K59.06%
2014-12-31$342.00K-30.35%
2014-09-30$491.00K11.34%
2014-06-30$441.00K-6.77%
2014-03-31$473.00K109.29%
2013-12-31$226.00K-45.93%
2013-09-30$418.00K-27.30%
2013-06-30$575.00K10.36%
2013-03-31$521.00K41.58%
2012-12-31$368.00K-39.07%
2012-09-30$604.00K100.00%
2012-06-30$302.00K-43.34%
2012-03-31$533.00K9.00%
2011-12-31$489.00K20.15%
2011-09-30$407.00K-36.11%
2011-06-30$637.00K-6.46%
2011-03-31$681.00K31.72%
2010-12-31$517.00K-16.88%
2010-09-30$622.00K-23.11%
2010-06-30$809.00K-18.20%
2010-03-31$989.00K24.87%
2009-12-31$792.00K11.39%
2009-09-30$711.00K34.91%
2009-06-30$527.00K-16.48%
2009-03-31$631.00K43.41%
2008-12-31$440.00K11.96%
2008-09-30$393.00K55.34%
2008-06-30$253.00K-34.63%
2008-03-31$387.00K-12.24%
2007-12-31$441.00K-

Nephros generated $4.88M in revenue during Q1 2025, up 26.02% compared to the previous quarter, and up 149.88% compared to the same period a year ago.

Nephros Revenue Breakdown

Nephros Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
Royalty and Other Revenues$127.00K$46.00K---
Other Revenue$121.00K$97.00K$46.00K$121.00K$40.00K
Royalty And Other Revenues-$128.00K---
License Royalty and Other Revenue---$200.00K$108.00K

Nephros's latest annual revenue breakdown by segment (product or service), as of Dec 24: Royalty and Other Revenues (51.21%), and Other Revenue (48.79%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25Dec 24Sep 24Mar 24Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
Product$4.31M$4.71M$3.47M-----------------
Royalty and Other Revenues-$171.00K$65.00K$46.00K$16.00K$8.00K$35.00K$16.00K$10.00K$54.00K$46.00K---------
Other Revenue-------$16.00K$10.00K$45.00K$10.00K$49.00K$27.00K$35.00K$10.00K$-5.00K$7.00K$38.00K$38.00K-
License Royalty and Other Revenue-----------$64.00K$42.00K$70.00K$24.00K$14.00K$27.00K$13.00K--
Product Revenues-------------------$3.12M

Nephros's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Product (100.00%).

Nephros Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BDSXBiodesix$71.32M$17.96M
TELATELA Bio$69.30M$20.20M
DXRDaxor$34.59M$36.35M
BDMDBaird Medical Investment$31.46M$6.57M
ICCCImmuCell$26.49M$8.07B
CTSOCytosorbents$25.13M$8.73M
ZJYLJin Medical$19.82M$9.57M
NEPHNephros$14.16M$4.88M
ICCMIceCure Medical$3.23M$736.35K
ACRVAcrivon Therapeutics--

NEPH Revenue FAQ

What is Nephros’s yearly revenue?

Nephros's yearly revenue for 2024 was $14.16M, representing a decrease of -0.53% compared to 2023. The company's yearly revenue for 2023 was $14.24M, representing an increase of 42.74% compared to 2022. NEPH's yearly revenue for 2022 was $9.98M, representing a decrease of -4.12% compared to 2021.

What is Nephros’s quarterly revenue?

Nephros's quarterly revenue for Q1 2025 was $4.88M, a 26.02% increase from the previous quarter (Q4 2024), and a 38.47% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $3.87M, a 10.01% increase from the previous quarter (Q3 2024), and a 18.93% increase year-over-year (Q4 2023). NEPH's quarterly revenue for Q3 2024 was $3.52M, a 8.18% increase from the previous quarter (Q2 2024), and a -5.99% decrease year-over-year (Q3 2023).

What is Nephros’s revenue growth rate?

Nephros's revenue growth rate for the last 3 years (2022-2024) was 41.97%, and for the last 5 years (2020-2024) was 65.42%.

What are Nephros’s revenue streams?

Nephros's revenue streams in c 24 are Royalty and Other Revenues, and Other Revenue. Royalty and Other Revenues generated $127K in revenue, accounting 51.21% of the company's total revenue, up 176.09% year-over-year. Other Revenue generated $121K in revenue, accounting 48.79% of the company's total revenue, up 24.74% year-over-year.

What is Nephros’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Nephros was Royalty and Other Revenues. This segment made a revenue of $127K, representing 51.21% of the company's total revenue.